1,475
Views
34
CrossRef citations to date
0
Altmetric
Original papers

Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats

, , &
Pages 111-115 | Received 16 Apr 2007, Accepted 20 Aug 2007, Published online: 08 Jul 2009

  • Adolphson P, Abbaszadegan H, Boden H, Salemyr M, Hen-riques T. Clodronate increases mineralization of callus after Colles’ fracture: a randomized, double-blind, placebo-controlled, prospective trial in 32 patients. Acta Orthop Scand 2000; 71(2)195–200
  • Aspenberg P. Drugs and fracture repair. Acta Orthop 2005; 76(6)741–8
  • Black D M, Greenspan S L, Ensrud K E, Palermo L, McGowan J A, Lang T F, Garnero P, Bouxsein M L, Bilezikian P, Rosen C J. The effects of parathyroid hormone and alendronate alone or in combination in post-menopausal osteoporosis. N Engl J Med 2003; 349(13)1207–15
  • Ettinger B, San Martin J, Crans G, Pavo I. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. J Bone Miner Res 2004; 19(5)745–51
  • Finkelstein J S, Hayes A, Hunzelman J L, Wyland J J, Lee H, Neer R M. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 2003; 349(13)1216–26
  • Finkelstein J S, Leder B Z, Burnett S A, Wyland J J, Lee H, de la Paz A V, Gibson K, Neer R M. Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men. J Clin Endocrinol Metab 2006; 91(8)2882–7
  • Gasser J A, Kneissel M, Thomsen J S, Mosekilde L. PTH and interactions with bisphosphonates. J Musculoskelet Neuronal Interact 2000; 1(1)53–6
  • Jeppsson C, Astrand J, Tagil M, Aspenberg P. A combination of bisphosphonate and BMP additives in impacted bone allografts. Acta Orthop Scand 2003; 74(4)483–9
  • Little D G, McDonald M, Bransford R, Godfrey C B, Amanat N. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model. J Bone Miner Res 2005; 20(11)2044–52
  • Ma Y L, Bryant H U, Zeng Q, Schmidt A, Hoover J, Cole H W, Yao W, Jee W S, Sato M. New bone formation with teriparatide [human parathyroid hormone-(1–34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats. Endocrinology 2003; 144(5)2008–15
  • Samadfam R, Xia Q, Goltzman D. Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice. J Bone Miner Res 2007; 22(1)55–63
  • Skripitz R, Aspenberg P. Early effect of parathyroid hormone (1–34) on implant fixation. Clin Orthop 2001a, 392: 427–32
  • Skripitz R, Aspenberg P. Implant fixation enhanced by intermittent treatment with parathyroid hormone. J Bone Joint Surg (Br) 2001b; 83(3)437–40
  • Skripitz R, Aspenberg P. Parathyroid hormone--a drug for orthopedic surgery?. Acta Orthop Scand 2004; 75(6)654–62
  • Tengvall P, Skoglund B, Askendal A, Aspenberg P. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials 2004; 25(11)2133–8
  • Wermelin K, Suska F, Tengvall P, Thomsen P, Aspenberg P. Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone. Histomor-phometry in rats. Bone 2007, in press

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.